Serone hires three, targets first US CLO by year-end
Serone's year-end goal would add a new issuer to the US CLO primary market as direct lending cools.
Serone Capital Management has added three people and is aiming to issue its first US CLO by the end of the year, Creditflux reported in an August 14 exclusive. The subscriber-gated story frames the additions as a push into US CLO management; the visible portion offers no names, no roles, and no target vehicle size.
The build comes at a moment when US direct lending has cooled. PWD's tracking shows this month's volume below half its first-quarter pace. Palmer Square is exploring a sale, and BlackRock TCP has sold nearly half its BDC portfolio into a continuation vehicle. Serone is staffing up for its first US deal.
Standing up a CLO platform is expensive. Warehouses, ratings, investor relationships, and a track record that takes years to build all must be in place before the first vehicle prices. Three hires is more than a minor experiment; the year-end date implies committed capital. A platform is a multi-year commitment, not a one-deal trade. Whether a warehouse is in place, or which banks are working on the deal, is unconfirmed — the published story does not say.
Serone is effectively choosing the securitization side of private credit while the direct-lending side digests. If US CLO issuance holds up, a fresh platform underwriting its first deal has no legacy book to defend. If issuance stalls, the cost of standing up the platform sits squarely with the manager.
A first US CLO within roughly four months would make Serone a fast mover in a market that usually rewards patience. A year-end deal leaves little room for the usual warehouse and ratings delays. If it lands, allocators gain another issuer in the primary market, and managers competing for loan collateral gain another bidder.